U.S. markets closed
  • S&P 500

    4,305.20
    +8.06 (+0.19%)
     
  • Dow 30

    34,152.01
    +239.61 (+0.71%)
     
  • Nasdaq

    13,102.55
    -25.55 (-0.19%)
     
  • Russell 2000

    2,020.53
    -0.82 (-0.04%)
     
  • Crude Oil

    86.83
    +0.30 (+0.35%)
     
  • Gold

    1,790.20
    +0.50 (+0.03%)
     
  • Silver

    20.09
    +0.01 (+0.05%)
     
  • EUR/USD

    1.0173
    +0.0008 (+0.08%)
     
  • 10-Yr Bond

    2.8240
    +0.0330 (+1.18%)
     
  • GBP/USD

    1.2096
    +0.0038 (+0.31%)
     
  • USD/JPY

    134.2940
    +1.0220 (+0.77%)
     
  • BTC-USD

    23,858.76
    -237.40 (-0.99%)
     
  • CMC Crypto 200

    569.15
    -2.76 (-0.48%)
     
  • FTSE 100

    7,536.06
    +26.91 (+0.36%)
     
  • Nikkei 225

    28,868.91
    -2.89 (-0.01%)
     

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of GenMark Diagnostics (Nasdaq - GNMK)

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BALA CYNWYD, PA / ACCESSWIRE / April 5, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of GenMark Diagnostics ("GenMark" or the "Company") (NASDAQ:GNMK) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to be acquired by Roche. Under the terms of the agreement, GenMark shareholders will receive only $24.05 in cash for each share they own.

The investigation concerns whether the GenMark Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Roche is paying too little for the Company.

If you own shares of GenMark stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, visit https://www.brodskysmith.com/cases/genmark-diagnostics-nasdaq-gnmk/, or call toll free 855-576-4847.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC



View source version on accesswire.com:
https://www.accesswire.com/639018/SHAREHOLDER-NOTICE-Brodsky-Smith-LLC-Announces-an-Investigation-of-GenMark-Diagnostics-Nasdaq--GNMK